Cell BioEngines, Inc.
PrivateLast Round
Seed
Jul 20, 2024
Total Funding Raised
$2.53M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cell BioEngines, Inc. is a biotechnology company that develops allogeneic 'off-the-shelf' stem cell and its derived therapies for human disease treatment, with a focus on oncology and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cell BioEngines, Inc. Comparables
Compare Cell BioEngines, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stratus Therapeutics | 88% | |
| Artiva | 74% | |
| Gamida Cell Ltd. | 73% | |
Cell BioEngines, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 20, 2024 | ||||
| Accelerator | Sep 13, 2023 |
Key People
Founding team and executive leadership
Cell BioEngines, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Empire State Development | Seed |
| Partnership for New York City | Seed |
| IndieBio | Accelerator |
| SOSV | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 68% MoM.
- Jul 20, 2024
$2M round led by SOSV and Empire State Development.
Cell BioEngines, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cell BioEngines, Inc.'s valuation, stock price, and market status.